WOCKHARDT
Back to Income Statement
|
WOCKHARDT Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-463 Cr | ₹-559 Cr | ₹-244 Cr | ₹686 Cr | ₹-69 Cr |
What is the latest Consolidated Net Profit of WOCKHARDT ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-463 Cr |
| Mar2024 | ₹-559 Cr |
| Mar2023 | ₹-244 Cr |
| Mar2022 | ₹686 Cr |
| Mar2021 | ₹-69 Cr |
How is Consolidated Net Profit of WOCKHARDT Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-463 Cr | Negative | |
| Mar2024 | ₹-559 Cr | Negative | |
| Mar2023 | ₹-244 Cr | Negative | |
| Mar2022 | ₹686 Cr | Positive | |
| Mar2021 | ₹-69 Cr | - | |
Compare Consolidated Net Profit of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹31,909.3 Cr | -2.4% | 15.2% | 16.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -2.4% |
15.2% |
16.6% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses